Markets were almost prepared for no rate cut in today's US Federal Reserve rate announcement and there was a muted reaction from Nasdaq, Dow Jones Industrial Average and S&P.

Kotak Mahindra Bank’s third-quarter performance for FY26 reinforces a familiar but increasingly convincing narrative: steady earnings delivery, disciplined balance sheet growth, and visible stabili

Axis Bank’s Q3FY26 performance marks a return to earnings normalcy, free of one-off distortions, even as margin pressures persist in a shifting rate environment.

Axis Securities has reiterated its BUY call on Kotak Mahindra Bank Limited, assigning a target price of Rs 515, implying an upside of 22% from current levels.

Indian Bank’s Q3FY26 performance underscores a phase of measured consolidation rather than aggressive expansion.

Gujarat Themis Biosyn Limited (GTBL), a niche pharmaceutical manufacturer specializing in fermentation-based intermediates, is entering a decisive phase of strategic evolution. BP Equities Pvt.